Harmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs. Established in 2017 by founder Paragon Biosciences LLC, our mission is to positively impact the lives of those living with rare diseases who are so often underserved.
Harmony has an experienced leadership team and a world class investor base, including affiliates of: Fidelity Management and Research Company; HBM Healthcare Investments; Novo Holdings; Paragon Biosciences, LLC; Valor Equity Partners; venBio Partners; Vivo Capital and Aisling Capital, among others. The company’s corporate headquarters are located in Plymouth Meeting, PA with offices in Chicago, IL and Washington DC.
More events are coming soon.
More information coming soon.